Insulin dysfunction and Tau pathology
- PMID: 24574966
- PMCID: PMC3920186
- DOI: 10.3389/fncel.2014.00022
Insulin dysfunction and Tau pathology
Abstract
The neuropathological hallmarks of Alzheimer's disease (AD) include senile plaques of β-amyloid (Aβ) peptides (a cleavage product of the Amyloid Precursor Protein, or APP) and neurofibrillary tangles (NFT) of hyperphosphorylated Tau protein assembled in paired helical filaments (PHF). NFT pathology is important since it correlates with the degree of cognitive impairment in AD. Only a small proportion of AD is due to genetic variants, whereas the large majority of cases (~99%) is late onset and sporadic in origin. The cause of sporadic AD is likely to be multifactorial, with external factors interacting with biological or genetic susceptibilities to accelerate the manifestation of the disease. Insulin dysfunction, manifested by diabetes mellitus (DM) might be such factor, as there is extensive data from epidemiological studies suggesting that DM is associated with an increased relative risk for AD. Type 1 diabetes (T1DM) and type 2 diabetes (T2DM) are known to affect multiple cognitive functions in patients. In this context, understanding the effects of diabetes on Tau pathogenesis is important since Tau pathology show a strong relationship to dementia in AD, and to memory loss in normal aging and mild cognitive impairment. Here, we reviewed preclinical studies that link insulin dysfunction to Tau protein pathogenesis, one of the major pathological hallmarks of AD. We found more than 30 studies reporting Tau phosphorylation in a mouse or rat model of insulin dysfunction. We also payed attention to potential sources of artifacts, such as hypothermia and anesthesia, that were demonstrated to results in Tau hyperphosphorylation and could major confounding experimental factors. We found that very few studies reported the temperature of the animals, and only a handful did not use anesthesia. Overall, most published studies showed that insulin dysfunction can promote Tau hyperphosphorylation and pathology, both directly and indirectly, through hypothermia.
Keywords: Alzheimer's disease; Tau phosphorylation; diabetes mellitus; kinases; phosphatases.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3920186/bin/fncel-08-00022-g0001.gif)
Similar articles
-
Insulin dysfunction induces in vivo tau hyperphosphorylation through distinct mechanisms.J Neurosci. 2007 Dec 12;27(50):13635-48. doi: 10.1523/JNEUROSCI.3949-07.2007. J Neurosci. 2007. PMID: 18077675 Free PMC article.
-
Anesthesia and tau pathology.Prog Neuropsychopharmacol Biol Psychiatry. 2013 Dec 2;47:147-55. doi: 10.1016/j.pnpbp.2013.03.004. Epub 2013 Mar 25. Prog Neuropsychopharmacol Biol Psychiatry. 2013. PMID: 23535147 Free PMC article. Review.
-
Neurobiology of Alzheimer's disease.Indian J Psychiatry. 2009 Jan;51(1):55-61. doi: 10.4103/0019-5545.44908. Indian J Psychiatry. 2009. PMID: 19742193 Free PMC article.
-
Alzheimer's disease.Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Subcell Biochem. 2012. PMID: 23225010 Review.
-
Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice.Acta Neuropathol. 2014 May;127(5):685-98. doi: 10.1007/s00401-014-1259-1. Epub 2014 Feb 15. Acta Neuropathol. 2014. PMID: 24531886
Cited by
-
Flavonoid-Rich Trianthema decandra Ameliorates Cognitive Dysfunction in the Hyperglycemic Rats.Biochem Genet. 2024 Apr 3. doi: 10.1007/s10528-024-10744-2. Online ahead of print. Biochem Genet. 2024. PMID: 38570442
-
Temporal and region-specific tau hyperphosphorylation in the medulla and forebrain coincides with development of functional changes in male obese Zucker rats.J Neurophysiol. 2024 Apr 1;131(4):689-708. doi: 10.1152/jn.00409.2023. Epub 2024 Feb 28. J Neurophysiol. 2024. PMID: 38416718 Free PMC article.
-
Interaction of Proteins Involved in Neuronal Proteinopathies.Life (Basel). 2023 Sep 23;13(10):1954. doi: 10.3390/life13101954. Life (Basel). 2023. PMID: 37895336 Free PMC article. Review.
-
Physiological Mechanisms Inherent to Diabetes Involved in the Development of Dementia: Alzheimer's Disease.Neurol Int. 2023 Oct 10;15(4):1253-1272. doi: 10.3390/neurolint15040079. Neurol Int. 2023. PMID: 37873836 Free PMC article. Review.
-
Exendin-4 ameliorates tau hyperphosphorylation and cognitive impairment in type 2 diabetes through acting on Wnt/β-catenin/NeuroD1 pathway.Mol Med. 2023 Sep 4;29(1):118. doi: 10.1186/s10020-023-00718-2. Mol Med. 2023. PMID: 37667187 Free PMC article.
References
-
- Alonso A. D., Grundke-Iqbal I., Barra H. S., Iqbal K. (1997). Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau. Proc. Natl. Acad. Sci. U.S.A. 94, 298–303 10.1073/pnas.94.1.298 - DOI - PMC - PubMed
-
- Andjelkovic M., Jakubowicz T., Cron P., Ming X. F., Han J. W., Hemmings B. A. (1996). Activation and phosphorylation of a pleckstrin homology domain containing protein kinase (RAC-PK/PKB) promoted by serum and protein phosphatase inhibitors. Proc. Natl. Acad. Sci. U.S.A. 93, 5699–5704 10.1073/pnas.93.12.5699 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources